ASTH vs GIB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 22, 2026

ASTH

60.9
AI Score
VS
ASTH Wins

GIB

59.2
AI Score

Investment Advisor Scores

ASTH

61score
Recommendation
BUY

GIB

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ASTH GIB Winner
Forward P/E 23.0415 10.9409 GIB
PEG Ratio 0 1.1986 Tie
Revenue Growth 42.9% 7.7% ASTH
Earnings Growth -97.7% 5.7% GIB
Tradestie Score 60.9/100 59.2/100 ASTH
Profit Margin 0.7% 10.2% GIB
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD ASTH

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.